ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2023

No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer.

Hao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.